| 产品名称: | Streptococcus agalactiae Lehmann and Neumann |
|---|---|
| 商品货号: | TS191812 |
| Strain Designations: | A909 |
| Isolation: | Clinical specimen - septic human neonate, 1934 |
| Biosafety Level: | 2 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties: | Lancefields group B, serotype Ia |
| Product Format: | freeze-dried |
| Storage Conditions: | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®: | no |
| Genome Sequenced Strain: | Streptococcus agalactiae A909, complete genome. |
| Type Strain: | no |
| Comments: | Genome sequenced strain |
| Medium: | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions: | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor: | AL Jones |
| Special Collection: | ATCC |
| References: | Lancefield RC, et al. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J. Exp. Med. 142: 165-179, 1975. PubMed: 1097573 |
| Cross References: | Nucleotide (GenBank) : CP000114 Streptococcus agalactiae A909, complete genome. |